HCPLive
APRIL 5, 2024
This analysis highlights trends following the significant update made to the Global Initiative for Asthma and the National Heart Lung and Blood Institute asthma guidelines.
Dr. Paddy Barrett
APRIL 5, 2024
This newsletter focuses on prevention. A common feedback I get is that people with existing coronary artery disease feel like it doesn’t apply to them. They feel like they have ‘ missed the boat ’ They have not. And I will explain why. Arguably, applying the principles of prevention offers more bang for buck in the short term for people WITH coronary artery disease than those without coronary artery disease.
JAMA Cardiology
APRIL 5, 2024
This systematic review and meta-analysis evaluates associations between antibiotic prophylaxis and infective endocarditis following invasive dental procedures.
DAIC
APRIL 5, 2024
Getty Images milla1cf Fri, 04/05/2024 - 09:57 April 5, 2024 — Johnson & Johnson and Shockwave Medical , Inc. today announced that they have entered into a definitive agreement under which Johnson & Johnson will acquire all outstanding shares of Shockwave for $335.00 per share in cash, corresponding to an enterprise value of approximately $13.1 billion including cash acquired.
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
JAMA Cardiology
APRIL 5, 2024
This cohort study explores whether a novel artificial intelligence (AI) video-based biomarker for aortic stenosis is associated with development and progression of aortic stenosis.
Med Page Today
APRIL 5, 2024
(MedPage Today) -- Commercially insured youths with type 2 diabetes were less likely to see specialists compared with their counterparts with type 1 diabetes, a cross-sectional study of claims data indicated. In propensity score-weighted analyses.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
Frontiers in Cardiovascular Medicine
APRIL 5, 2024
Inhaled nitric oxide (NO) has been used in pediatric and adult perioperative cardiac intensive care for over three decades. NO is a cellular signaling molecule that induces smooth muscle relaxation in the mammalian vasculature. Inhaled NO has the unique ability to exert its vasodilatory effects in the pulmonary vasculature without any hypotensive side-effects in the systemic circulation.
Cardiomatics
APRIL 5, 2024
In a world where technology reigns supreme, one of the most profound tools in medicine remains the irreplaceable electrocardiogram (ECG). This noninvasive method provides a graphical visualization of millivolt potentials received by electrodes located on the patient’s skin. It can measure many aspects, from how fast the heart beats to how well its chambers conduct electrical energy.
HeartRhythm
APRIL 5, 2024
The advent of artificial intelligence (AI) in healthcare has opened new frontiers in patient care and medical consultation. Among the most innovative applications of this technology are medical chatbots, which have the potential to revolutionize the way health advice and information are delivered to patients. By leveraging advanced algorithms and vast medical knowledge databases, these chatbots promise to provide immediate, accessible, and personalized medical advice.
The New England Journal of Medicine
APRIL 5, 2024
A number of therapies that have been shown to be effective in patients with chronic heart failure, including beta-blockers, mineralocorticoid receptor antagonists, and renin–angiotensin system inhibitors, have also been shown to be beneficial in patients with evidence of left ventricular systolic dysfunction, pulmonary congestion, or both after an acute myocardial.
HCPLive
APRIL 5, 2024
National data show older Americans with vision impairment were less likely to have access to digital technology than counterparts without impairments.
American College of Cardiology
APRIL 5, 2024
In this panel discussion, host Andrea Price MS, AACC brings together Martina Speight FNP-BC, MS, Jane Linderbaum ARNP, CNP, FACC and Bailey Estes MSN, AGNP-C to explore best practices related to structural heart disease.
HCPLive
APRIL 5, 2024
Katie Abouzahr, MD, explains the transformative potential of nipocalimab for the treatment of patients with autoantibody-driven conditions.
American College of Cardiology
APRIL 5, 2024
In this episode, Editor-in-Chief of the ACC FIT section, Dr. Mohamad Khattab, interviews Dr. Julia Grapsa, who provides tips on how to publish your science from the perspective of an editor who regularly reviews manuscript submissions.
HCPLive
APRIL 5, 2024
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics including treatment eligibility, diagnostics, and service delivery.
Journal of Cardiothoracic Surgery
APRIL 5, 2024
To analyze the relationship between the thickness of the left atrial posterior wall and the low and no voltage zones in the left atrial posterior wall in patients with atrial fibrillation (AF).
DAIC
APRIL 5, 2024
milla1cf Fri, 04/05/2024 - 21:37 April 5, 2024 — The Cardiovascular Research Foundation (CRF) has announced New York Valves: The Structural Heart Summit , the expanded next iteration of our renowned annual Transcatheter Valve Therapy (TVT) conference. Taking place June 5-7, 2024, at the Jacob K. Javits Convention Center, North in New York City, the new summit will be a world-class educational experience in the field of structural heart interventions.
Journal of Cardiothoracic Surgery
APRIL 5, 2024
The management of hemostasis in patients medicated with apixaban (Eliquis) undergoing emergency cardiac surgery is exceedingly difficult. The body’s natural elimination pathways for apixaban prove ineffective.
DAIC
APRIL 5, 2024
milla1cf Fri, 04/05/2024 - 21:34 April 5, 2024 — Cardiawave SA , a French medtech company that has developed an innovative Non-Invasive focused Ultrasound Therapy (NIUT) device for the treatment of severe symptomatic calcific aortic stenosis, will present the 30-day follow-up results for 60 patients enrolled in its European pivotal study to the 73rd annual conference of the American College of Cardiology in Atlanta, Georgia.
Journal of Cardiothoracic Surgery
APRIL 5, 2024
Coronary artery fistula (CAF) is characterized as a congenital or acquired abnormal communication between a coronary artery and any of the four chambers of the heart (coronary–cameral fistula) or great vessels.
DAIC
APRIL 5, 2024
milla1cf Fri, 04/05/2024 - 21:37 April 5, 2024 — The Cardiovascular Research Foundation (CRF) is excited to introduce New York Valves: The Structural Heart Summit , the expanded next iteration of our renowned annual Transcatheter Valve Therapy (TVT) conference. Taking place June 5-7, 2024, at the Jacob K. Javits Convention Center, North in New York City, the new summit will be a world-class educational experience in the field of structural heart interventions.
HCPLive
APRIL 5, 2024
Philip J Mease, MD, highlights recent data comparing the safety and efficacy of bimekizumab with other DMARDs for the treatment of PsA.
Physiologically Speaking
APRIL 5, 2024
Greetings! Welcome to the Physiology Friday newsletter. ICYMI On Monday, I posted a video interview that I recorded with Aidan Chariton from Shortcut U. We discuss the importance of endurance training and other things related to human health and performance. On Wednesday, I posted my “7 Rules for Health.” Details about the sponsors of this newsletter including Examine.com and my book “VO2 Max Essentials ” can be found at the end of the post!
HCPLive
APRIL 5, 2024
This clinical quiz will test your knowledge of iron deficiency anemia, focused on the gastrointestinal evaluation of anemia based on recommendations from the AGA's 2020 guidelines.
The American Journal of Cardiology
APRIL 5, 2024
Publication date: Available online 4 April 2024 Source: The American Journal of Cardiology Author(s): Shruti Revankar, Anandita Agarwala
HCPLive
APRIL 5, 2024
Physician assistants TJ Chao and Kristine Kucera discuss how the understanding of plaque psoriasis has changed over time and is now considered a systemic disease.
Circulation: Heart Failure
APRIL 5, 2024
Circulation: Heart Failure, Ahead of Print.
HCPLive
APRIL 5, 2024
TJ Chao and Kristine Kucera, PA’s go into dept of the recent developments in the systemic oral space of plaque psoriasis.
The New England Journal of Medicine
APRIL 5, 2024
The identification of an inverse association between high-density lipoprotein (HDL) cholesterol levels and incident cardiovascular disease events,1 combined with research on the role of HDL in reverse cholesterol transport, led to the exploration of therapies directed toward increasing HDL cholesterol. However, although therapies such as cholesteryl-ester transfer protein.
HCPLive
APRIL 5, 2024
Dermatologists Drs Tina Bhutani and Scott Boswell discuss how patients with generalized pustular psoriasis (GPP) typically present in the hospital.
HeartRhythm
APRIL 5, 2024
A 28-year-old man with recurrent palpitations and no structural heart disease presented with a documented wide QRS complex tachycardia (WCT). He had a history of slow pathway ablation for atrioventricular nodal reentrant tachycardia three months ago. A standard electrophysiologic study was performed using multipolar-electrode catheters in the high right atrium, His bundle, right ventricular apex, and coronary sinus.
HCPLive
APRIL 5, 2024
A patient and dermatologists discuss flare-ups and episodic nature of generalized pustular psoriasis (GPP).
HeartRhythm
APRIL 5, 2024
The aorta-mitral annulus conjunction (AMC) is uncommon site of origin of focal atrial tachycardias (AT). Hence, the electrophysiological and ablation target characteristics are poorly described.
HCPLive
APRIL 5, 2024
Experts discuss the use of TNF blockers in treating plaque psoriasis and their limited but important uses today.
HeartRhythm
APRIL 5, 2024
Mastectomy with lymphadenectomy is a common surgical approach for patients with breast cancer. The risk of breast surgical site infection after mastectomy could be more than 10%1. Cardiovascular implantable electronic devices (CIED) implantation in these patients presents unique challenges due to the postoperative lymph node disturbance. However, there is currently no study assessing infection and vascular complication risks in these patients post-CIED implantation.
HCPLive
APRIL 5, 2024
Experts discuss the landscape of IL therapies for the treatment of psoriasis, highlighting their improved safety and efficacy over prior agents.
Expert insights. Personalized for you.
120 
Let's personalize your content